MetaImmuneTech Inc. – Trademark Portfolio

Entity Type: 03

MetaImmuneTech Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CELLYTICS. The owner is based in Sejong-si.

No. 310, 2511, Sejong-ro, Jochiwon-eup

Sejong-si 30019 , KR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MetaImmuneTech Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MetaImmuneTech Inc. have?

MetaImmuneTech Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does MetaImmuneTech Inc. file in?

MetaImmuneTech Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are MetaImmuneTech Inc.'s most well-known trademarks?

MetaImmuneTech Inc.'s registered trademark portfolio includes well-known marks such as CELLYTICS. These are among 2 currently registered trademarks in the portfolio.

What is MetaImmuneTech Inc.'s trademark registration success rate?

MetaImmuneTech Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.